PORTAGE, Mich. - Stryker (NYSE:SYK) announced today the launch of TPX HD, a small bone power tool designed for orthopaedic procedures including total joint revisions, minimally invasive surgery and oral maxillofacial procedures.
The device features a tapered attachment design for visibility in confined spaces and a housing designed to manage motor heat at high speeds, according to a company press release. The handpiece has a shorter length compared to previous models.The product launch comes as Stryker, with a market capitalization of $114.8 billion, continues to strengthen its position in the healthcare equipment sector. According to InvestingPro analysis, the stock currently appears undervalued relative to its Fair Value, trading near its 52-week low at $299.46. The company maintains strong fundamentals with revenue of $25.27 billion and is one of 1,400+ US equities covered by comprehensive Pro Research Reports.
"Revision procedures are some of the most demanding cases surgeons face, especially when metal cutting is involved," said Mike Carlin, president of Stryker’s Ortho Tech division. "TPX HD was designed with those moments in mind, when visibility is limited, precision matters and surgeons need a tool they can trust to perform."
The system delivers up to 296% more torque compared to the TPX Micro Drill at high speed and operates 40% faster than the TPX Micro Drill at high speed, the company stated. The tool integrates with Stryker’s CORE 2 Console through I.D. Touch software, which allows surgeons to adjust drill response and sensitivity settings.
The TPX HD includes multiple attachment lengths, a PROStep 5:1 reducer and attachments for metal and bone cement cutting and removal.
Stryker manufactures medical technology products in the MedSurg, Neurotechnology and Orthopaedics segments.
In other recent news, Stryker Corporation reported its first-quarter 2026 earnings, which were significantly affected by a cyber incident. The company missed both earnings and revenue forecasts, posting an earnings per share (EPS) of $2.60 compared to the anticipated $2.98, and revenue of $6 billion against the expected $6.34 billion. Despite the setback, Stryker reaffirmed its 2026 guidance. Argus responded by lowering its price target on Stryker shares from $435 to $350, while maintaining a Buy rating, citing the cyberattack’s impact on operations and financial performance. In other developments, Stryker’s shareholders re-elected all ten members of the board of directors during the annual meeting. The company also announced a quarterly dividend of $0.88 per share, representing a 4.8% increase from the previous year. This dividend is set to be paid on July 31, 2026, to shareholders of record as of June 30, 2026.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
ProPicks AI evaluates SYK alongside thousands of other companies every month using 100+ financial metrics. Using powerful AI to generate exciting stock ideas, it looks beyond popularity to assess fundamentals, momentum, and valuation. The AI has no bias—it simply identifies which stocks offer the best risk-reward based on current data with notable past winners that include Super Micro Computer (+185%) and AppLovin (+157%). Want to know if SYK is currently featured in any ProPicks AI strategies, or if there are better opportunities in the same space?